Abbott's new line of on-body biowearables for consumers, including a version for athletes, debuted at CES 2022 – where Abbott was also the show's first healthcare keynote (via CES)

Health takes cen­ter stage at an­nu­al CES tech bash with ad­vanced wear­ables, tele­health deals and lat­est in Covid test­ing

From biowear­ables to smart at-home health care and mon­i­tor­ing, health tech­nol­o­gy took cen­ter­stage at CES last week. Lit­er­al­ly, in fact, with Ab­bott pre­sent­ing the first-ever health­care keynote at the an­nu­al sem­i­nal tech fest.

Ab­bott, which makes FreeStyle Li­bre blood glu­cose mon­i­tors, took the spot­light op­por­tu­ni­ty to an­nounce its move in­to con­sumer biowear­ables. Its new­ly un­veiled line of Lin­go prod­ucts will track and mea­sure not on­ly glu­cose, but al­so lac­tate and ke­tones and even­tu­al­ly al­co­hol lev­els. Build­ing on its glu­cose tech, the fu­ture prod­ucts cen­ter on a sim­i­lar cir­cu­lar wear­able patch that con­stant­ly mon­i­tors meta­bol­ic blood mark­ers and re­ports re­sults through a smart­phone app.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.